Intelligent three-dimensional imaging in pathology: Applications and developments
- 11 School of Optical and Electronic Information, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China
- 22 Wuhan Smartview Biotechnology Co., Ltd, Wuhan, Hubei 430074, China
- 33 Institution of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China
Abstract
Conventional two-dimensional (2D) pathology relies on a limited number of tissue sections and therefore provides information from isolated planes, which can introduce sampling bias and lead to the loss of axial details, making it difficult to accurately capture the full structural organization of tumors and their microenvironment. In recent years, the integration of three-dimensional (3D) imaging technologies, such as tissue clearing and light-sheet fluorescence microscopy, combined with virtual staining, artificial intelligence, and spatial omics, has enabled the acquisition and analysis of volumetric biological information while preserving the overall architecture of the tissue. Following the theme of “advancing from planar observation to 3D quantitative analysis”, this paper outlines the major technical pathways of 3D pathology, from sample clearing and fluorescent labeling to 3D imaging and visualization and then to an analytical framework for 3D pathological data. Based on this, we further examined representative applications, including tumor staging, lesion detection, and immune microenvironment profiling, to illustrate the advantages and potential clinical value of 3D pathology over conventional 2D approaches in precision diagnosis, prognostic assessment, and therapeutic decision-making. We also highlight key challenges that remain for 3D pathology, such as storage and computational costs, workflow and diagnostic standardization, and clinical implementation. Overall, AI-enabled 3D pathological imaging holds promise as an important direction for pathology, although its integration into routine clinical decision-making will require continued technological development and translational research.
Related
- From Static Atlases to Intelligent Learning Systems: A Scoping Review of Imaging-Based Tools and Emerging Artificial Intelligence Applications for Facial Aesthetic Education and Training
- Capillary hemangioma of the breast presenting as a new mass on screening mammography: A case report with imaging-pathology correlation
- Sex-related differences in cardiovascular physiology and pathology: insights from cardiac imaging
- Integrating multiparametric imaging and electrophysiology reveals thalamic pathology
- Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data.
BibTeX
@article{si2026intelligent,
title = {{Intelligent three-dimensional imaging in pathology: Applications and developments}},
author = {Wentian Si and Fang Zhao and Dong Kuang and Yuxuan Zhao and Yanchen Liu and Minglu Sun and Yaqi Duan and Peng Fei and Guoping Wang and Jing Ni},
journal = {Chinese Medical Journal},
year = {2026},
month = jun,
doi = {10.1097/cm9.0000000000004176},
url = {https://doi.org/10.1097/cm9.0000000000004176},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Intelligent three-dimensional imaging in pathology: Applications and developments
AU - Wentian Si
AU - Fang Zhao
AU - Dong Kuang
AU - Yuxuan Zhao
AU - Yanchen Liu
AU - Minglu Sun
AU - Yaqi Duan
AU - Peng Fei
AU - Guoping Wang
AU - Jing Ni
PY - 2026
DA - 2026/06/17
JO - Chinese Medical Journal
DO - 10.1097/cm9.0000000000004176
UR - https://doi.org/10.1097/cm9.0000000000004176
AB - Conventional two-dimensional (2D) pathology relies on a limited number of tissue sections and therefore provides information from isolated planes, which can introduce sampling bias and lead to the loss of axial details, making it difficult to accurately capture the full structural organization of tumors and their microenvironment. In recent years, the integration of three-dimensional (3D) imaging technologies, such as tissue clearing and light-sheet fluorescence microscopy, combined with virtual staining, artificial intelligence, and spatial omics, has enabled the acquisition and analysis of volumetric biological information while preserving the overall architecture of the tissue. Following the theme of “advancing from planar observation to 3D quantitative analysis”, this paper outlines the major technical pathways of 3D pathology, from sample clearing and fluorescent labeling to 3D imaging and visualization and then to an analytical framework for 3D pathological data. Based on this, we further examined representative applications, including tumor staging, lesion detection, and immune microenvironment profiling, to illustrate the advantages and potential clinical value of 3D pathology over conventional 2D approaches in precision diagnosis, prognostic assessment, and therapeutic decision-making. We also highlight key challenges that remain for 3D pathology, such as storage and computational costs, workflow and diagnostic standardization, and clinical implementation. Overall, AI-enabled 3D pathological imaging holds promise as an important direction for pathology, although its integration into routine clinical decision-making will require continued technological development and translational research.
SN - 0366-6999
SN - 2542-5641
ER -